Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Ablynx signs Nanobodies collaboration agreement with Novartis

Jan. 20, 2006

Caprion and Icos form new biomarker research collaboration

Jan. 20, 2006

Emisphere discloses novel drug delivery agents

Jan. 19, 2006

Inovio and Tripep sign agreement for HCV vaccine development

Jan. 19, 2006

Evotec and Boehringer Ingelheim expand drug discovery collaboration

Jan. 18, 2006

Human Genome Sciences and Amgen sign license agreement

Jan. 17, 2006

Chemicon and MorphoSys sign licensing agreement for research antibodies

Jan. 17, 2006

Ablynx and Centocor sign Nanobodies agreement

Jan. 16, 2006

Sangamo and Pfizer expand research collaboration

Jan. 11, 2006

Xencor and Roche extend research collaboration

Jan. 10, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...